Byrne, M J <br/><br/>
Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Jan 1999 
 - 25-30 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1999.17.1.25  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cisplatin--administration & dosage<br/>Deoxycytidine--administration & dosage<br/>Disease Progression<br/>Female<br/>Humans<br/>Male<br/>Mesothelioma--diagnostic imaging<br/>Middle Aged<br/>Pleural Neoplasms--diagnostic imaging<br/>Survival Rate<br/>Tomography, X-Ray Computed<br/>Gemcitabine